20.8.2026 | China – The Next Growth Market for Finnish Health Technology
Tapahtuman tiedot
Ajankohta
-
20.8.2026 Helsinki | China – The Next Growth Market for Finnish Health Technology
Date: 20 August 2026 at 10:00 -13:00
Location: Eteläranta 10, Helsinki, Finland
Organisers: Healthtech Finland & Team Finland China
About the Event
China’s healthcare ecosystem is evolving rapidly and is increasingly becoming a source of innovation, commercialisation opportunities, strategic partnerships, and growth capital. This event aims to help Finnish health technology companies better understand opportunities across the Chinese healthcare market and evaluate China as a potential growth and export market.
The discussion will cover opportunities in medical technology, digital health, diagnostics, healthcare investment, market access, and partnership development.
Target Audience
CEOs, founders, business development leaders, and decision-makers from Finnish health technology, medtech, biotech, diagnostics, and digital health companies interested in exploring opportunities in China.
Programme
Opening Remarks (5 min)
Saara Hassinen, Healthtech Finland
China Healthcare Market Outlook
Chun Wu, Conston Consulting Group (BCG)
Finnish Company Experiences on entering China market
Petra Furu, Medix Biochemica
Mikko Karvinen, Nexstim
Jukka Holappa, AQ Biotech
Noam David Stern, Nordic Life Science Platform (case Thermidas)
How Team Finland China can support your company?
Marko Tiesmäki, Minister Counsellor, Business and Trade Promotion, Embassy of Finland Beijing
Investor perspectives about China market
Networking Lunch
Speaker Brief: China Healthcare Market Outlook
For the China Healthcare Market Outlook session, we hope to provide Finnish health technology companies with a strategic overview of opportunities across China’s health technology, medical device, in vitro diagnostics (IVD), digital health, and healthy ageing sectors. The presentation may explore emerging opportunities under China’s 15th Five-Year Plan, the rapid development of China’s medical device and diagnostics ecosystem, the growing adoption of AI-enabled diagnostics and digital healthcare, as well as practical insights on market entry strategies, partnership models, regional market selection, regulatory considerations, and commercial opportunities for Finnish companies looking to expand into the Chinese healthcare market.
Speaker Brief: Investor Perspectives
For the Investor Perspectives session, we hope to provide insights into the evolving investment landscape across China’s biotech, medtech, and digital health sectors, highlighting key growth areas, investment themes, and opportunities for international companies. We would welcome an investor’s perspective on how Finnish healthcare companies can position themselves for success in China, including partnership and commercialisation strategies, fundraising opportunities, collaboration with Chinese industry players, access to growth capital, and practical considerations for building a sustainable long-term presence in the Chinese market.
